ALTHE — Theraclion SA Share News
0.000.00%
Last trade - 00:00- €41.86m
- €43.43m
- €1.19m
Brief: Theraclion H1 Sales Jump To EUR 0.9 Mln
Brief: Theraclion: Announces Phase-2 Collaboration With University Of Virginia Cancer Center
Brief: Theraclion FY Operating Loss Narrows To 4.3 Million Euros
Brief: Theraclion 2020 Turnover At 744,000 Euros, Down 73% YoY
Brief: Theraclion Announces Renewed Investor Confidence
Brief: Theraclion Announces Positive Results For Its SONOVEIN Echotherapy Solution
Brief: Theraclion Ready To Launch 2nd Generation Of SONOVEIN
Brief: Theraclion H1 Net Loss Widens To 1.9 Million Euros
Brief: Theraclion FY Sales Up 44%
Brief: Theraclion H1 EBIT Loss Narrows To 2.2 Million Euros
Brief: Theraclion H1 Sales Up At 1 Mln Euros
Brief: Theraclion Announces First Commercial Agreement For Its SONOVEIN Solution
Brief: Theraclion Announces Four Systems Sales And Major Reimbursement Agreement
Brief: Theraclion Obtains A CE Mark For The Non-Invasive Treatment Of Varicose Veins
Brief: Theraclion FY Net Loss Almost Flat YOY At EUR 6.1 Million
Brief: Theraclion FY Total Sales Down At 1.9 Million Euros
Brief: Theraclion Sells First Echopulse System To German Speaking Switzerland
Brief: Theraclion H1 Operating Loss Of 4.1 Million Euros
Brief: Theraclion Says Its Research Program Has Been Selected As A Eurostars Project